Prospective study to assess the efficacy and safety of different doses of antihistamines in treating chronic spontaneous urticaria
Not Applicable
Recruiting
- Conditions
- Health Condition 1: null- Chronic spontaneous urticaria
- Registration Number
- CTRI/2016/07/007099
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 96
Inclusion Criteria
1.Patients >18 years of age
2.Patients fulfilling the definition of chronic spontaneous urticaria which is urticarial lesions occurring most days of the week (atleast 3 times a week) lasting for 6 weeks or more with no identifiable cause on history or examination.
Exclusion Criteria
1. Patients less than 18 years of age,
2. Patients unwilling to participate in the study,
3. Patients with physical, contact, drug-induced urticaria and urticarial vasculitis
4. Pregnant or breast-feeding females
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients achieving complete control of urticaria with varying doses of antihistaminesTimepoint: From September 2014 to September 2015
- Secondary Outcome Measures
Name Time Method â?¢Change in Urticaria Activity Score (UAS7) <br/ ><br>â?¢Change in quality-of-life as measured by CUQ2oL <br/ ><br>â?¢Degree of sedation experienced as reported by the patients <br/ ><br>Timepoint: From September 2014 to September 2015